Tag: CSE:MMJ

February 25, 2020

Matica Subsidiary Receives Sales Licence

Matica is pleased to announce that its subsidiary has received both the Standard Processing and Sale For Medical Purposes Licences...
February 12, 2020

Matica’s Interest in RoyalMax Released

Matica Enterprises Inc. (CSE:MMJ) (Frankfurt:39N) (OTCQB:MMJFF) is pleased to announce that Matica has closed the RoyalMax Biotechnology Canada Inc. acquisition.
December 18, 2019

Matica Welcomes Roop Mundi To The Board

Matica Enterprises Inc. is pleased to welcome Mr. Roop Mundi to the board of directors of the Company, subject to...
December 4, 2019

Construction Permits Received for Hemmingford Greenhouse Project

Matica Enterprises Inc. is pleased to report that the Company has obtained construction permits for the greenhouse project in Hemmingford,...
November 6, 2019

RoyalMax Submits for Health Canada Sales and Processing Licence

Matica Enterprises Inc. is pleased to announce that RoyalMax Biotechnology Canada Inc. has submitted to Health Canada applications for amendments.
September 18, 2019

Matica Sales Licence Update

Matica Enterprises Inc. provides an update on the status of the applications for licences by RoyalMax Biotechnology Canada Inc. ("RoyalMax")...
August 16, 2019

Matica Launches Odour Neutralizing Ionic Mist

Matica Enterprises Inc. (CSE:MMJ, OTCQB:MMJFF) (Frankfurt:39N) ("Matica" or the "Company") is pleased to announce the launch of a much anticipated new product,...